Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Edible seaweeds: a potential novel source of bioactive metabolites and nutraceuticals with human health benefits
There has been an increase in human health concerns, and seaweeds are considered as a
potential functional food which can decrease the risk of many diseases, as they contain …
potential functional food which can decrease the risk of many diseases, as they contain …
Clinical and economic burden of adverse drug reactions
Adverse drug reactions (ADRs) are unwanted drug effects that have considerable economic
as well as clinical costs as they often lead to hospital admission, prolongation of hospital …
as well as clinical costs as they often lead to hospital admission, prolongation of hospital …
Systematic reviews: synthesis of best evidence for clinical decisions
Systematic reviews can help practitioners keep abreast of the medical literature by
summarizing large bodies of evidence and hel** to explain differences among studies on …
summarizing large bodies of evidence and hel** to explain differences among studies on …
External validity of randomised controlled trials:“to whom do the results of this trial apply?”
PM Rothwell - The Lancet, 2005 - thelancet.com
In making treatment decisions, doctors and patients must take into account relevant
randomised controlled trials (RCTs) and systematic reviews. Relevance depends on …
randomised controlled trials (RCTs) and systematic reviews. Relevance depends on …
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
G Palareti, N Leali, S Coccheri, M Poggi, C Manotti… - The Lancet, 1996 - thelancet.com
Background Bleeding is the most serious complication of the use of oral anticoagulation in
the prevention and treatment of thromoboembolic complications. We studied the frequency …
the prevention and treatment of thromoboembolic complications. We studied the frequency …
The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
J Ansell, J Hirsh, L Poller, H Bussey, A Jacobson… - Chest, 2004 - Elsevier
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the Seventh American College of Chest Physicians Conference …
antagonists (VKAs) is part of the Seventh American College of Chest Physicians Conference …
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis
LA Linkins, PT Choi, JD Douketis - Annals of internal medicine, 2003 - acpjournals.org
Background: Clinicians should consider the clinical impact of anticoagulant-related bleeding
when deciding on the duration of anticoagulant therapy in patients with venous …
when deciding on the duration of anticoagulant therapy in patients with venous …
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin
BF Gage, C Van Walraven, L Pearce, RG Hart… - Circulation, 2004 - ahajournals.org
Background—The rate of stroke in atrial fibrillation (AF) depends on the presence of
comorbid conditions and the use of antithrombotic therapy. Although adjusted-dose warfarin …
comorbid conditions and the use of antithrombotic therapy. Although adjusted-dose warfarin …
Pharmacogenomics and individualized drug therapy
M Eichelbaum, M Ingelman-Sundberg… - Annu. Rev …, 2006 - annualreviews.org
Pharmacogenetics deals with inherited differences in the response to drugs. The best-
recognized examples are genetic polymorphisms of drug-metabolizing enzymes, which …
recognized examples are genetic polymorphisms of drug-metabolizing enzymes, which …